Risk Factors Update Summary
- Recent executive turnover may harm business operations. New leadership may impact strategic goals.
- Potential negative impact from pending securities fraud action against the Company and former officers.
- Litigation from activist stockholders could negatively affect the Company's business and operations.
- The Company may need to raise additional capital to fund operations, with potential dilution risks.
- Material weaknesses in internal controls over financial reporting related to ITGCs, inventory controls, and risk assessment.
- Changes in strategic or operating goals due to new executives may create uncertainty.
- Termination of distribution agreement with ZO Skin Health may impact revenue. In 2023, revenue from skincare products decreased from $42.5 million to $34.0 million.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1162461&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.